Medicare

Medicare’s Prescription Drug Plan Makeover Transcript

‘Medicare’s Prescription Drug Plan Makeover’ Transcript October 27, 2022 Note: This transcript has been created with a combination of machine ears and human eyes. There may be small differences between this document and the audio version, which is one of many reasons we encourage you to listen to the episode! Listen in Apple Podcasts Listen on Spotify…

Read More

Medicare’s Prescription Drug Plan Makeover 

An overhaul of Medicare’s prescription drug benefit will lower costs for seniors while changing incentives for insurers and drugmakers.

Read More

Medicare Open Enrollment

Leslie Walker shares four research studies to explain the stakes of Medicare open enrollment.

Read More

The Race to Prepare for Medicare’s New Drug Pricing Powers

Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

Read More

Dems’ New Drug Pricing Deal: What You Need to Know

Stacie Duestzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.

Read More

Looking for Causes of Racial Disparities in Medicare Advantage

Adrianna McIntyre shares new research showing non-white communities have less access to high quality Medicare Advantage plans.

Read More

High-Price Drugs Out of Reach for Many on Medicare

Bianca Frogner breaks down new research on the impact subsidies can have for people on Medicare trying to access lifesaving drugs.

Read More

How One Alzheimer’s Drug Is Changing the U.S. Drug Approval Conversation

Taking stock of the impact of the Aduhelm saga and Medicare’s decision to restrict coverage of the controversial treatment.

Read More

Are Vets Less Likely to Die at VA Hospitals?

Amal Trivedi shares research looking at what happens to veterans who get emergency care at VA vs. non-VA hospitals.

Read More

Ways to Save in Budget Busting Medicare Part B

Stacie Dusetzina shares new research showing the difference in spending on Part B drugs in Medicare and Medicare Advantage.

Read More